NCT07072676View on ClinicalTrials.gov

The Use of Assistive Gait Devices Can Reduce the Risk of Falls in Patients With Neuromuscular Diseases Following a Training Period.

NAEnrolling by invitationINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

September 1, 2025

Primary Completion Date

May 1, 2027

Study Completion Date

August 1, 2028

Conditions
Inclusion Body MyositisMyotonic Dystrophy 1Myotonic Dystrophy 2Facio-Scapulo-Humeral DystrophyLimb Girdle Muscular DystrophiesPompe Disease (Infantile-Onset)Myasthaenia GravisLambert Eaton (LEMS)Spinal Muscular Atrophy (SMA)Guillain Barré SyndromeChronic Inflammatory Demyelinating PolyneuropathyFriedreich AtaxiaHereditary Motor and Sensory Neuropathies
Interventions
DEVICE

Assistive gait devices combined with physiotherapy

During the intervenation week, the patient undergoes 12 hours/week of gait training, fall prevention, balance group and physiotherapy as part of their inpatient rehabilitation programme. The individual sessions last 30 minutes each.

Trial Locations (1)

53075

Medical Park, Bad Feilnbach, Reithofpark, Bad Feilnbach

All Listed Sponsors
lead

LMU Klinikum

OTHER